Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research Across Europe
Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research Across Europe Company expands portfolio of next-generation sequencing immuno-oncology and liquid biopsy assays to meet demand for a multi-disciplinary approach to cancer research AMSTERDAM and MADRID and CARLSBAD, Calif., Aug. 31, 2017 /PRNewswire/ — Thermo Fisher Scientific has formed the Immuno-Oncology Consortium to drive adoption of highly sensitive, next-generation... Read more